Catalyst Pharmaceutical CPRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $221.32M+3.3% | $214.33M-1.5% | $217.56M+4.3% | $208.67M+5.7% | $197.35M+20.4% | ||
| $330K-12.0% | $375K-10.1% | $417K-7.5% | $451K+5.9% | $426K+7.3% | ||
| $25.19M+1.7% | $24.78M+2.0% | $24.29M+5.4% | $23.04M+16.1% | $19.85M-10.8% | ||
| $208.21M-0.2% | $208.67M-11.1% | $234.66M-14.7% | $275.09M+2.7% | $267.93M+11.7% | ||
| $85K+46.6% | $58K-49.1% | $114K-69.4% | $373K+4.5% | $357K-35.8% | ||
| -$85K-46.6% | -$58K+49.1% | -$114K+69.4% | -$373K-4.5% | -$357K+35.8% | ||
| $33.55M+32.6% | $25.3M+33.3% | $18.98M+50.0% | $12.65M+100% | $6.33M— | ||
| -$32.93M-93.8% | -$16.99M-231% | $13.02M+55.6% | $8.37M-3.3% | $8.65M-94.1% | ||
| $175.2M-8.6% | $191.62M-22.6% | $247.56M-10.7% | $277.11M+2.5% | $270.25M-28.9% | ||
| $208.13M-0.2% | $208.61M-11.1% | $234.54M-14.6% | $274.72M+2.7% | $267.57M+11.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Catalyst Pharmaceutical generate?
- Catalyst Pharmaceutical (CPRX) generated $208.2M in operating cash flow over the trailing twelve months.
- What is Catalyst Pharmaceutical's free cash flow?
- After $85.0K of capital expenditures, Catalyst Pharmaceutical's free cash flow was $208.1M over the trailing twelve months, down 22.2% year over year.
- Where does Catalyst Pharmaceutical's cash flow data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
